Delivery Order SPE2DB22D3016-SPE2DB24FBAA4

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $78K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider, is for the delivery of Fingolimod 0.5 mg capsules. The contract, valued at $100,246.99, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a period of performance through October 17, 2024. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,526.70 Firm Fixed Price Delivery Order covers the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award, valued at $43,771.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a medication used to treat certain medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of December 23, 2024. This award is part of Amerisourcebergen's larger...
This federal contract award, valued at $3,819.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a prescription medication. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award of $62,452.57 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fingolimod 0.5 mg capsules. The contract is a firm fixed-price delivery order with a completion date of November 19, 2024. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has an extensive history of providing pharmaceutical products and medical supplies to...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $5,489.88 and has a performance period through January 27, 2025. It is for the procurement of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $36,021.49, is a delivery order contract with a firm fixed price pricing type. It was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that serves military and veteran healthcare programs. The contract is for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a medication used to treat certain medical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $26,089.45, is a delivery order for the procurement of Fingolimod 0.5mg 30s, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2023 and is a firm fixed-price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) valued...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,705.27 firm fixed-price delivery order is for Fingolimod 0.5mg 30s, a prescription medication. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $51,412.21, is for the delivery of Fingolimod 0.5 mg capsules to support military and federal healthcare programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBAA4
    Delivery Order

This federal contract award, valued at $78,113.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication, to support military healthcare programs.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award was not designated with any set-aside requirements, indicating open competition. No subcontractors were mentioned in the provided information.

Generated 5/17/25, 10:00 AM